Apr 18, 2011

Lifting of suspension of Octagam recommended

The European Medicines Agency (EMA)’s Committee for Human Medicinal Products (CHMP) has recommended the lifting of the suspension of the marketing authorisations for Octagam (human normal immunoglobulin 5% and 10%) and associated names, and the reintroduction of the medicine onto the market in the European Union. For more information please see:

http://www.ema.europa.eu/ema/index.jsp? … 058004d5c1

World PI Week
IPOPI would be grateful for any support to the important work for primary immunodeficiencies.

Read all

Executive Director: Johan Prevot
Email: johan@ipopi.org
Tel/Fax: +351 21 407 5720
UK office
Firside Main Road Downderry
Cornwall PL11 3LE
United Kingdom

Tel: +44 1503 250 668
Fax: +44 1503 250 961
E-mail: info@ipopi.org
IPOPI is a charity registered in the UK.
Registration No. 1058005